PubMed · 2023

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England journal of medicine.

The New England journal of medicine

View original source

Peptides linked in PeptIQ Wiki

Semaglutide — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.